Literature DB >> 15760928

Functional haplotypes of PADI4: relevance for rheumatoid arthritis specific synovial intracellular citrullinated proteins and anticitrullinated protein antibodies.

T Cantaert1, P Coucke, L De Rycke, E M Veys, F De Keyser, D Baeten.   

Abstract

BACKGROUND: Haplotypes of PADI4, encoding for a citrullinating enzyme, were associated with rheumatoid arthritis in a Japanese population. It was suggested they were related to the presence of anticitrullinated protein antibodies (ACPA).
OBJECTIVE: To explore the relation between PADI4 haplotypes, the presence of rheumatoid arthritis specific intracellular citrullinated proteins in synovial membrane, and serum ACPA titres.
METHODS: Synovial biopsies and peripheral blood samples were obtained in 59 patients with rheumatoid arthritis. Synovial intracellular citrullinated proteins were detected by immunohistochemistry. Serum ACPA titres were measured by anti-CCP2 ELISA. PADI4 haplotypes were determined by direct sequencing of the four exonic PADI4 single nucleotide polymorphisms.
RESULTS: PADI4 haplotype frequencies and the presence of synovial intracellular citrullinated proteins and ACPA were comparable with previous studies. There was no significant association between PADI4 haplotype 1 or 2 and the presence of synovial intracellular citrullinated proteins, although these proteins were associated with higher serum ACPA. There was no correlation between PADI4 haplotypes and serum ACPA, either by continuous analysis using the titres or by dichotomous analysis using the diagnostic cut off. Further analyses in homozygotes for haplotype 1 or 2 or in heterozygotes (1/2) also failed to show an association between PADI4 polymorphisms and ACPA. This contrasted with the clear association between ACPA levels and HLA-DR shared epitope.
CONCLUSIONS: The link between synovial intracellular citrullinated proteins and ACPA emphasises the role of deimination of synovial proteins in rheumatoid arthritis, but the biological relevance of the PADI4 haplotypes for this autoimmune process is questionable, at least in a European population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15760928      PMCID: PMC1755666          DOI: 10.1136/ard.2004.033548

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  16 in total

1.  Is expression of intracellular citrullinated proteins in synovial tissue specific for rheumatoid arthritis? Comment on the article by Baeten et al.

Authors:  T J M Smeets; E R Vossenaar; W J van Venrooij; P P Tak
Journal:  Arthritis Rheum       Date:  2002-10

2.  The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues.

Authors:  E Girbal-Neuhauser; J J Durieux; M Arnaud; P Dalbon; M Sebbag; C Vincent; M Simon; T Senshu; C Masson-Bessière; C Jolivet-Reynaud; M Jolivet; G Serre
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

3.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

4.  The presence of citrullinated proteins is not specific for rheumatoid synovial tissue.

Authors:  Erik R Vossenaar; Tom J M Smeets; Maarten C Kraan; Jos M Raats; Walther J van Venrooij; Paul P Tak
Journal:  Arthritis Rheum       Date:  2004-11

5.  Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.

Authors:  G A Schellekens; B A de Jong; F H van den Hoogen; L B van de Putte; W J van Venrooij
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

6.  Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis.

Authors:  Akari Suzuki; Ryo Yamada; Xiaotian Chang; Shinya Tokuhiro; Tetsuji Sawada; Masakatsu Suzuki; Miyuki Nagasaki; Makiko Nakayama-Hamada; Reimi Kawaida; Mitsuru Ono; Masahiko Ohtsuki; Hidehiko Furukawa; Shinichi Yoshino; Masao Yukioka; Shigeto Tohma; Tsukasa Matsubara; Shigeyuki Wakitani; Ryota Teshima; Yuichi Nishioka; Akihiro Sekine; Aritoshi Iida; Atsushi Takahashi; Tatsuhiko Tsunoda; Yusuke Nakamura; Kazuhiko Yamamoto
Journal:  Nat Genet       Date:  2003-08       Impact factor: 38.330

7.  A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population.

Authors:  Anne Barton; John Bowes; Stephen Eyre; Kristian Spreckley; Anne Hinks; Sally John; Jane Worthington
Journal:  Arthritis Rheum       Date:  2004-04

8.  Diagnostic classification of spondylarthropathy and rheumatoid arthritis by synovial histopathology: a prospective study in 154 consecutive patients.

Authors:  Dominique Baeten; Elli Kruithof; Leen De Rycke; Bernard Vandooren; Bart Wyns; Luc Boullart; Ilse E A Hoffman; Annemieke M Boots; Eric M Veys; Filip De Keyser
Journal:  Arthritis Rheum       Date:  2004-09

Review 9.  History and diagnostic value of antibodies to citrullinated proteins in rheumatoid arthritis.

Authors:  I Peene; L De Rycke; D Baeten; I Hoffman; E M Veys; F De Keyser
Journal:  Int J Immunopathol Pharmacol       Date:  2004 May-Aug       Impact factor: 3.219

10.  Cox-2: Where are we in 2003? - The role of cyclooxygenase-2 in bone repair.

Authors:  Thomas A Einhorn
Journal:  Arthritis Res Ther       Date:  2002-10-21       Impact factor: 5.156

View more
  4 in total

1.  Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.

Authors:  Z Reyes-Castillo; C A Palafox-Sánchez; I Parra-Rojas; G E Martínez-Bonilla; S del Toro-Arreola; M G Ramírez-Dueñas; G Ocampo-Bermudes; José F Muñoz-Valle
Journal:  Clin Exp Immunol       Date:  2015-09-16       Impact factor: 4.330

2.  Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis.

Authors:  Michelle L Harris; Erika Darrah; Gordon K Lam; Susan J Bartlett; Jon T Giles; Audrey V Grant; Peisong Gao; William W Scott; Hani El-Gabalawy; Livia Casciola-Rosen; Kathleen C Barnes; Joan M Bathon; Antony Rosen
Journal:  Arthritis Rheum       Date:  2008-07

3.  PADI2 is significantly associated with rheumatoid arthritis.

Authors:  Xiaotian Chang; Yifang Xia; Jihong Pan; Qingsong Meng; Yan Zhao; Xinfeng Yan
Journal:  PLoS One       Date:  2013-12-05       Impact factor: 3.240

4.  Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study.

Authors:  Berthold Hoppe; Thomas Häupl; Rudolf Gruber; Holger Kiesewetter; Gerd R Burmester; Abdulgabar Salama; Thomas Dörner
Journal:  Arthritis Res Ther       Date:  2006-01-16       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.